Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
21.87
+0.24 (1.11%)
Dec 3, 2024, 12:36 PM EST - Market open
Upstream Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -53.4 | -20.54 | -23.87 |
| Depreciation & Amortization | 0.05 | 0.06 | 0.01 |
| Loss (Gain) From Sale of Investments | -2.59 | -1.26 | - |
| Stock-Based Compensation | 4.73 | 3.43 | 1.28 |
| Other Operating Activities | -3.64 | -15.31 | 0.15 |
| Change in Accounts Receivable | -0.34 | 0.31 | -0.41 |
| Change in Accounts Payable | 4.65 | 1.28 | 0.46 |
| Change in Other Net Operating Assets | -4.52 | -5.9 | 3.36 |
| Operating Cash Flow | -55.67 | -37.93 | -19.02 |
| Capital Expenditures | -0.33 | -0.14 | -0.08 |
| Investment in Securities | -106.31 | -82.7 | - |
| Investing Cash Flow | -106.64 | -82.84 | -0.08 |
| Issuance of Common Stock | 0.13 | 0.12 | - |
| Other Financing Activities | -1.79 | - | -0.04 |
| Financing Cash Flow | 148.13 | 129.55 | 9.96 |
| Net Cash Flow | -14.18 | 8.78 | -9.14 |
| Free Cash Flow | -56 | -38.07 | -19.1 |
| Free Cash Flow Margin | -2537.20% | -1599.58% | -1576.16% |
| Free Cash Flow Per Share | -19.55 | -13.52 | -6.82 |
| Levered Free Cash Flow | - | -25.88 | - |
| Unlevered Free Cash Flow | - | -25.88 | - |
| Change in Net Working Capital | - | 4.23 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.